文献速递肺结节与肺癌

阻断补体C5a/C5aR1轴通过CXCL16介导效应 impair 肺癌骨转移

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.
PubMed 文献 · Am J Respir Crit Care Med · 2018-01-01

该研究探讨补体C5a/C5aR1轴对非小细胞肺癌细胞恶性表型尤其是骨定植的影响。通过数据库分析与免疫组化验证C5aR1表达与临床结局的关联,并在体内外模型中评估基因沉默与配体抑制的功能意义。结果显示肺癌细胞中C5aR1高表达与更短的无复发生存、总生存及骨转移显著相关,阻断该轴可减少骨转移负荷与骨溶解,该效应与破骨细胞生成活性下降相关并可被外源性CXCL16挽救。

要点

  • 肺癌C5aR1高表达与更短无复发生存、总生存及骨转移显著相关。
  • 沉默C5aR1或l-aptamer阻断可减少体内骨转移负荷与骨溶解。
  • 该效应与破骨细胞生成活性下降相关,可被外源CXCL16挽救。

核心结论

  • 破坏肺癌细胞中C5aR1信号可削弱其肿瘤相关破骨细胞生成活性,损害骨定植。
  • 本研究揭示C5a/C5aR1轴在肺癌播散中的作用,支持其作为新治疗靶点的潜力。

研究设计与样本

  • 研究采用in silico分析评估C5aR1表达与临床结局的关联,并用免疫组化验证。
  • 通过慢病毒基因沉默与配体l-aptamer抑制在肺癌骨转移体内模型中评估功能意义。
  • 体外进行信号传导、迁移、侵袭、金属蛋白酶活性及破骨细胞生成等功能实验。

主要发现

  • 人肺癌中C5aR1高表达与更短的无复发生存、总生存及骨转移显著相关。
  • 沉默肺癌细胞C5aR1导致体内模型中骨转移负荷与骨溶解大幅减少。
  • C5aR1刺激或基因沉默可在体外调节肿瘤细胞的金属蛋白酶解、迁移与侵袭活性。
  • l-aptamer阻断或C5aR1沉默显著降低肺癌细胞体内骨转移活性。
  • 该效应与体外破骨细胞生成活性下降相关,并可被外源性CXCL16挽救。

临床怎么用

  • C5aR1高表达或可作为肺癌骨转移风险与预后评估的候选生物标志物。
  • 靶向C5a/C5aR1轴可能成为抑制肺癌骨转移的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: C5aR1 (CD88), a receptor for complement anaphylatoxin C5a, is a potent immune mediator. Its impact on malignant growth and dissemination of non-small cell lung cancer cells is poorly understood. OBJECTIVES: To investigate the contribution of the C5a/C5aR1 axis to the malignant phenotype of non-small cell lung cancer cells, particularly in skeletal colonization, a preferential lung metastasis site. METHODS: Association between C5aR1 expression and clinical outcome was assessed in silico and validated by immunohistochemistry. Functional significance was evaluated by lentiviral gene silencing and ligand l-aptamer inhibition in in vivo models of lung cancer bone metastasis. In vitro functional assays for signaling, migration, invasion, metalloprotease activity, and osteoclastogenesis were also performed. MEASUREMENTS AND MAIN RESULTS: High levels of C5aR1 in human lung tumors were significantly associated with shorter recurrence-free survival, overall survival, and bone metastasis. Silencing of C5aR1 in lung cancer cells led to a substantial reduction in skeletal metastatic burden and osteolysis in in vivo models. Furthermore, metalloproteolytic, migratory, and invasive tumor cell activities were modulated in vitro by C5aR1 stimulation or gene silencing. l-Aptamer blockade or C5aR1 silencing significantly reduced the osseous metastatic activity of lung cancer cells in vivo. This effect was associated with decreased osteoclastogenic activity in vitro and was rescued by the exogenous addition of the chemokine CXCL16. CONCLUSIONS: Disruption of C5aR1 signaling in lung cancer cells abrogates their tumor-associated osteoclastogenic activity, impairing osseous colonization. This study unveils the role played by the C5a/C5aR1 axis in lung cancer dissemination and supports its potential use as a novel therapeutic target.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Ajona D, Zandueta C, Corrales L, et al. Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects. Am J Respir Crit Care Med. 2018. PMID: 29327939. doi:10.1164/rccm.201703-0660OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。